CSIMarket Company Name, Ticker, Suppliers, else..
 

Gri Bio Inc   (NASDAQ: GRI)

Gri Bio Inc 's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

GRI Sales vs. its Competitors Q2 2026


Comparing the current results to its competitors, Gri Bio Inc reported Revenue decrease in the 2 quarter 2026 year on year by 0 %, despite the revenue increase by the most of its competitors of 10.63 %, recorded in the same quarter.

• List of GRI Competitors





Revenue Growth Comparisons




Net Income Comparison

Gri Bio Inc , faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<<  GRI Stock Performance Comparisons





*Market share is calculated based on total revenue.





Publicly Traded Peers of Gri Bio Inc




Beone Medicines Ltd
Share Performance



+6.37%
One Year
Beone Medicines Ltd
Profile

The company focuses on the discovery and development of oncology treatments for cancer patients globally.

More about Beone Medicines Ltd 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 519,364.909 mill. $ 6,128.238 mill. $ 655.707 mill.


Nexien Biopharma Inc
Share Performance



0.00%
Over The Past 5 Days
Nexien Biopharma Inc
Profile

Nexien Biopharma Inc operates as a biotechnology company focused on the development and commercialization of innovative therapies for various medical conditions. They aim to use their expertise in biopharmaceutical research to bring novel treatments to market, improving patient outcomes and meeting unmet medical needs.

More about Nexien Biopharma Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 0.007 mill. $ - mill. $ -0.188 mill.


Protokinetix Incorporated
Share Performance



-50.00%
30 Days
Protokinetix Incorporated
Profile

Protokinetix Incorporated's business model revolves around the commercialization of its proprietary technology, AAGP™ (Antifreeze Protein Analog).

More about Protokinetix Incorporated's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 0.077 mill. $ - mill. $ -0.394 mill.


Allarity Therapeutics Inc
Share Performance



-18.32%
This Quarter
Allarity Therapeutics Inc
Profile

Allarity Therapeutics Inc is a biotechnology company that leverages its unique drug response profiling platform to develop personalized cancer treatments. They use AI algorithms to match patients with the most effective therapies by analyzing their individual molecular profiles.

More about Allarity Therapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 20.923 mill. $ - mill. $ -12.334 mill.


Medicure Inc
Share Performance



0.00%
30 Days
Medicure Inc
Profile

Medicure Inc operates as a pharmaceutical company with a business model that focuses on the research, development, and commercialization of innovative cardiovascular and other specialty pharmaceuticals. They aim to address unmet medical needs, improve patient outcomes, and deliver value to healthcare providers and consumers.

More about Medicure Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ - mill. $ 25.925 mill. $ -5.920 mill.

62 more competitors available

Sign in to see all competitors

Sign In Create Free Account

Sources: Gri Bio Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Gri Bio Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.